Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 94990

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 18, 2024
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
FDC Limited

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, [NDC 64980-514-05].

D-0632-2024
Recall number
D-0632-2024
Initiated
July 18, 2024
Classification
Class II
Status
Ongoing
Recalling firm
FDC Limited
Quantity
362,544 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective container; yellow colored spike from cap lodged in the nozzle

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective container; yellow colored spike from cap lodged in the nozzle

Code information

Lot Number: 083J022, Expiration Date: September- 25; 083L046, Expiration date: November- 25; 083H009, Expiration date: July- 25

Distribution pattern

Nationwide in the US